Skip to content

Study · Not a test of the peptide alone · 1990

2 results

Application of thymic factor "Thymalin" in complex treatment of endometrial cancer patients.

Bakhidze EV, Bokhman JaV

European journal of gynaecological oncology1 Jan 1990

PMID2245808 (opens in a new tab)PepBankPUB-02245808
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In endometrial cancer patients, complex treatment containing Thymalin had positive effects on cell immunity.

    In plain wordsIn patients with endometrial cancer, complex treatment containing Thymalin improved cellular immunity.

    Peptide
    Thymalin
    Outcome
    IncreaseCell immunity
    Study

    n = 35

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Its positive effects on cell immunity and some clinico-morphological parameters have been registered.
    1 context sentence
    Summary · context
    35 patients received thymic factor "Thymalin" as a component of complex treatment.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In endometrial cancer patients, complex treatment containing Thymalin had positive effects on unspecified clinico-morphological parameters.

    In plain wordsIn patients with endometrial cancer, complex treatment containing Thymalin improved unspecified clinical and tissue parameters.

    Peptide
    Thymalin
    Outcome
    Direction not reportedClinico-morphological parameters
    Study

    n = 35

    Outcome group
    Cancer treatment response · Cancer

    Source sentences

    Summary
    Its positive effects on cell immunity and some clinico-morphological parameters have been registered.
    1 context sentence
    Summary · context
    35 patients received thymic factor "Thymalin" as a component of complex treatment.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.